MCP-1 is overexpressed in triple-negative breast cancers and drives cancer invasiveness and metastasis
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MCP-1 is overexpressed in triple-negative breast cancers and drives cancer invasiveness and metastasis
Authors
Keywords
MCP-1, TNBC, Metastasis, MAP kinase
Journal
BREAST CANCER RESEARCH AND TREATMENT
Volume 170, Issue 3, Pages 477-486
Publisher
Springer Nature
Online
2018-03-28
DOI
10.1007/s10549-018-4760-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- GROα overexpression drives cell migration and invasion in triple negative breast cancer cells
- (2017) Kruttika Bhat et al. ONCOLOGY REPORTS
- Adipocytes and Macrophages Interplay in the Orchestration of Tumor Microenvironment: New Implications in Cancer Progression
- (2017) Luís Henrique Corrêa et al. Frontiers in Immunology
- miRpower: a web-tool to validate survival-associated miRNAs utilizing expression data from 2178 breast cancer patients
- (2016) András Lánczky et al. BREAST CANCER RESEARCH AND TREATMENT
- Paracrine Interactions between Adipocytes and Tumor Cells Recruit and Modify Macrophages to the Mammary Tumor Microenvironment: The Role of Obesity and Inflammation in Breast Adipose Tissue
- (2015) Ana Santander et al. Cancers
- Molecular mechanisms of epithelial–mesenchymal transition
- (2014) Samy Lamouille et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Chemotherapy-enhanced inflammation may lead to the failure of therapy and metastasis
- (2014) Dinesh Vyas et al. OncoTargets and Therapy
- Adipose tissue and adipocytes support tumorigenesis and metastasis
- (2013) Kristin M. Nieman et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Molecularly targeted therapies for metastatic triple-negative breast cancer
- (2013) Soley Bayraktar et al. BREAST CANCER RESEARCH AND TREATMENT
- Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
- (2013) J. Gao et al. Science Signaling
- Triple-negative breast cancer: epidemiological considerations and recommendations
- (2012) P. Boyle ANNALS OF ONCOLOGY
- CCL2/CCR2 Chemokine Signaling Coordinates Survival and Motility of Breast Cancer Cells through Smad3 Protein- and p42/44 Mitogen-activated Protein Kinase (MAPK)-dependent Mechanisms
- (2012) Wei Bin Fang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
- (2012) Christina Curtis et al. NATURE
- Obesity is associated with breast cancer in African-American women but not Hispanic women in South Los Angeles
- (2011) Marianna Sarkissyan et al. CANCER
- Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
- (2011) Brian D. Lehmann et al. JOURNAL OF CLINICAL INVESTIGATION
- CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis
- (2011) Bin-Zhi Qian et al. NATURE
- Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
- (2010) Kai Kessenbrock et al. CELL
- Chemotherapy Induces Macrophage Chemoattractant Protein-1 Production in Ovarian Cancer
- (2010) Melissa A. Geller et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Characteristics of triple-negative breast cancer
- (2010) Tim C. de Ruijter et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Biomarkers for epithelial-mesenchymal transitions
- (2009) Michael Zeisberg et al. JOURNAL OF CLINICAL INVESTIGATION
- Monocyte Chemoattractant Protein-1 (MCP-1): An Overview
- (2009) Satish L. Deshmane et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- The inflammatory chemokines CCL2 and CCL5 in breast cancer
- (2008) Gali Soria et al. CANCER LETTERS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started